• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.一种用于辅助早期非小细胞肺癌肺叶切除术与肺段切除术选择的风险评分
Ann Thorac Surg. 2016 Dec;102(6):1814-1820. doi: 10.1016/j.athoracsur.2016.06.032. Epub 2016 Sep 1.
2
Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.肺切除术后第二原发性肺癌的肺切除术:一项基于人群的研究。
Ann Thorac Surg. 2017 Oct;104(4):1131-1137. doi: 10.1016/j.athoracsur.2017.04.043. Epub 2017 Jul 12.
3
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.亚肺叶切除术与肺叶切除术在实性结节临床Ⅰ A 期肺癌中的疗效相当。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23.
4
Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.亚肺叶切除术与老年T1a期非小细胞肺癌的肺叶切除术疗效相当:一项监测、流行病学和最终结果数据库分析
J Surg Res. 2016 Feb;200(2):683-9. doi: 10.1016/j.jss.2015.08.045. Epub 2015 Sep 3.
5
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.临床ⅠA 期肺癌的长期结果:肺叶切除术与亚肺叶切除术比较。
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
6
Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.老年早期非小细胞肺癌手术治疗中叶下切除与肺叶切除的对比研究(STEPS):一项随机对照试验的研究方案
Trials. 2016 Apr 7;17:191. doi: 10.1186/s13063-016-1312-6.
7
Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.临床I A期肺癌肺叶下切除与肺叶切除术后的生存率:来自国家癌症数据库的分析
J Thorac Oncol. 2015 Nov;10(11):1625-33. doi: 10.1097/JTO.0000000000000664.
8
Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.非小细胞肺癌肺叶和肺段切除术的疗效:单中心经验
South Med J. 2015 Apr;108(4):230-4. doi: 10.14423/SMJ.0000000000000272.
9
Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.≤1 厘米或>1 至 2 厘米的非小细胞肺癌患者的手术方式选择:肺叶切除术、节段切除术和楔形切除术:一项基于人群的研究。
J Clin Oncol. 2016 Sep 10;34(26):3175-82. doi: 10.1200/JCO.2015.64.6729. Epub 2016 Jul 5.
10
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.I 期非小细胞肺癌:波兰国家肺癌登记处肺叶切除术与亚肺叶切除术的长期结果。
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):363-369. doi: 10.1093/ejcts/ezx092.

引用本文的文献

1
Prognostic significance of tumor spread through air spaces and lymphovascular invasion in stage I non-small cell lung cancer: implications for adjuvant chemotherapy.I期非小细胞肺癌中肿瘤气腔播散和淋巴血管侵犯的预后意义:对辅助化疗的启示
World J Surg Oncol. 2025 Aug 28;23(1):325. doi: 10.1186/s12957-025-03980-2.
2
Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer.肺叶下切除术:早期肺癌的新护理标准。
Cancers (Basel). 2023 May 25;15(11):2914. doi: 10.3390/cancers15112914.
3
The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases.随着与健康相关的预期寿命降低,肺叶切除术相对于楔形切除术的生存优势减弱。
JTO Clin Res Rep. 2021 Jan 21;2(3):100143. doi: 10.1016/j.jtocrr.2021.100143. eCollection 2021 Mar.
4
Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection.对于I期非小细胞肺癌患者,立体定向体部放射治疗(SBRT)比肺叶下切除适用于更多的肿瘤。
J Thorac Dis. 2021 Mar;13(3):1576-1583. doi: 10.21037/jtd-20-2001.
5
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities.有肺部和心脏合并症的退伍军人的 I 期非小细胞肺癌的最佳治疗策略。
PLoS One. 2021 Mar 18;16(3):e0248067. doi: 10.1371/journal.pone.0248067. eCollection 2021.
6
Lobectomy versus sublobar resection in patients with non-small cell lung cancer: a systematic review.非小细胞肺癌患者肺叶切除术与肺段切除术的系统评价
J Thorac Dis. 2020 Jun;12(6):3357-3362. doi: 10.21037/jtd.2020.02.54.
7
How to predict the risk of post-lobectomy complications in elderly lung cancer patients.如何预测老年肺癌患者肺叶切除术后并发症的风险。
J Thorac Dis. 2019 May;11(Suppl 9):S1432-S1433. doi: 10.21037/jtd.2019.04.73.
8
Comparing open and closed chest surgery for early-stage lung cancer: still relevant?比较开放性与闭合性胸部手术治疗早期肺癌:仍有意义吗?
J Thorac Dis. 2019 May;11(Suppl 9):S1307-S1309. doi: 10.21037/jtd.2019.04.74.
9
The impact of insight on post-lobectomy complications.洞察对肺叶切除术后并发症的影响。
J Thorac Dis. 2019 Mar;11(Suppl 3):S289-S290. doi: 10.21037/jtd.2019.01.38.
10
Targeted surgical therapy for lung cancer.肺癌的靶向手术治疗
J Thorac Dis. 2018 Nov;10(Suppl 33):S3904-S3907. doi: 10.21037/jtd.2018.09.149.

本文引用的文献

1
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.美国临床IA期非小细胞肺癌的肺叶下切除术
Clin Lung Cancer. 2016 Jan;17(1):47-55. doi: 10.1016/j.cllc.2015.07.005. Epub 2015 Aug 3.
3
Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.临床I A期肺癌肺叶下切除与肺叶切除术后的生存率:来自国家癌症数据库的分析
J Thorac Oncol. 2015 Nov;10(11):1625-33. doi: 10.1097/JTO.0000000000000664.
4
Comparison of Two National Databases for General Thoracic Surgery.两个普通胸外科国家数据库的比较
Ann Thorac Surg. 2015 Oct;100(4):1155-61; discussion 1161-2. doi: 10.1016/j.athoracsur.2015.05.031. Epub 2015 Aug 25.
5
Non-Small Cell Lung Cancer, Version 6.2015.非小细胞肺癌临床实践指南(2015 年第 6 版)
J Natl Compr Canc Netw. 2015 May;13(5):515-24. doi: 10.6004/jnccn.2015.0071.
6
Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis.量化楔形切除术的安全性益处:一项胸外科医师协会数据库倾向匹配分析
Ann Thorac Surg. 2014 Nov;98(5):1705-11; discussion 1711-2. doi: 10.1016/j.athoracsur.2014.06.017. Epub 2014 Sep 4.
7
Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.结局:安大略省东南部癌症中心 1998 年至 2009 年间非小细胞肺癌行楔形切除术与肺叶切除术的对比。
Can J Surg. 2013 Dec;56(6):E165-70. doi: 10.1503/cjs.006311.
8
Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer.亚肺叶切除术为老年早期肺癌患者提供了与肺叶切除术相当的生存获益。
Ann Thorac Surg. 2010 Nov;90(5):1651-6. doi: 10.1016/j.athoracsur.2010.06.090.
9
Sublobar resection: a movement from the Lung Cancer Study Group.亚肺叶切除术:来自肺癌研究组的一项举措。
J Thorac Oncol. 2010 Oct;5(10):1583-93. doi: 10.1097/jto.0b013e3181e77604.
10
STS database risk models: predictors of mortality and major morbidity for lung cancer resection.STS 数据库风险模型:肺癌切除术死亡率和主要发病率的预测因素。
Ann Thorac Surg. 2010 Sep;90(3):875-81; discussion 881-3. doi: 10.1016/j.athoracsur.2010.03.115.

一种用于辅助早期非小细胞肺癌肺叶切除术与肺段切除术选择的风险评分

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.

作者信息

Gulack Brian C, Yang Chi-Fu Jeffrey, Speicher Paul J, Yerokun Babatunde A, Tong Betty C, Onaitis Mark W, D'Amico Thomas A, Harpole David H, Hartwig Matthew G, Berry Mark F

机构信息

Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, California.

出版信息

Ann Thorac Surg. 2016 Dec;102(6):1814-1820. doi: 10.1016/j.athoracsur.2016.06.032. Epub 2016 Sep 1.

DOI:10.1016/j.athoracsur.2016.06.032
PMID:27592602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5140083/
Abstract

BACKGROUND

The long-term survival benefit of lobectomy over sublobar resection for early-stage non-small cell lung cancer must be weighed against a potentially increased risk of perioperative mortality. The objective of the current study was to create a risk score to identify patients with favorable short-term outcomes following lobectomy.

METHODS

The 2005-2012 American College of Surgeons National Surgical Quality Improvement Program database was queried for patients undergoing a lobectomy or sublobar resection (either segmentectomy or wedge resection) for lung cancer. A multivariable logistic regression model was utilized to determine factors associated with 30-day mortality among the lobectomy group and to develop an associated risk score to predict perioperative mortality.

RESULTS

Of the 5,749 patients who met study criteria, 4,424 (77%) underwent lobectomy, 1,098 (19%) underwent wedge resection, and 227 (4%) underwent segmentectomy. Age, chronic obstructive pulmonary disease, previous cerebrovascular event, functional status, recent smoking status, and surgical approach (minimally invasive versus open) were utilized to develop the risk score. Patients with a risk score of 5 or lower had no significant difference in perioperative mortality by surgical procedure. Patients with a risk score greater than 5 had significantly higher perioperative mortality after lobectomy (4.9%) as compared to segmentectomy (3.6%) or wedge resection (0.8%, p < 0.01).

CONCLUSIONS

In this study, we have developed a risk model that predicts relative operative mortality from a sublobar resection as compared to a lobectomy. Among patients with a risk score of 5 or less, lobectomy confers no additional perioperative risk over sublobar resection.

摘要

背景

对于早期非小细胞肺癌,肺叶切除术相对于肺段以下切除术的长期生存获益必须与围手术期死亡风险可能增加相权衡。本研究的目的是创建一个风险评分,以识别肺叶切除术后短期预后良好的患者。

方法

查询2005 - 2012年美国外科医师学会国家外科质量改进计划数据库中接受肺癌肺叶切除术或肺段以下切除术(肺段切除术或楔形切除术)的患者。采用多变量逻辑回归模型确定肺叶切除组中与30天死亡率相关的因素,并制定相关风险评分以预测围手术期死亡率。

结果

在符合研究标准的5749例患者中,4424例(77%)接受了肺叶切除术,1098例(19%)接受了楔形切除术,227例(4%)接受了肺段切除术。利用年龄、慢性阻塞性肺疾病、既往脑血管事件、功能状态、近期吸烟状态和手术方式(微创与开放)来制定风险评分。风险评分为5或更低的患者,不同手术方式的围手术期死亡率无显著差异。风险评分大于5的患者,肺叶切除术后围手术期死亡率(4.9%)显著高于肺段切除术(3.6%)或楔形切除术(0.8%,p < 0.01)。

结论

在本研究中,我们开发了一种风险模型,可预测与肺叶切除术相比肺段以下切除术的相对手术死亡率。在风险评分为5或更低的患者中,肺叶切除术与肺段以下切除术相比,围手术期无额外风险。